Document:

EX-10.1

 Exhibit 10.1 

STOCK PURCHASE AGREEMENT 

by and between 
 ZOSANO,
INC. 
 and 
 ZP
HOLDINGS, INC. 
 October 31, 2013 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	Article I DEFINITIONS	  	 	1	  
		
	 Article II PURCHASE AND SALE OF COMMON STOCK
	  	 	3	  
			
	 2.1
	 	Sale and Issuance of Common Stock	  	 	3	  
	 2.2
	 	Closing	  	 	4	  
		
	 Article III REPRESENTATIONS AND WARRANTIES OF BUYER
	  	 	4	  
			
	 3.1
	 	Organization and Qualification	  	 	4	  
	 3.2
	 	Authority Relative to this Agreement; Non-Contravention	  	 	4	  
	 3.3
	 	No Conflicts	  	 	5	  
	 3.4
	 	Purchase for Own Account	  	 	5	  
	 3.5
	 	Disclosure of Information	  	 	5	  
	 3.6
	 	Restricted Securities	  	 	5	  
	 3.7
	 	Accredited Investor	  	 	6	  
	 3.8
	 	No General Solicitation	  	 	6	  
		
	 Article IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	  	 	6	  
			
	 4.1
	 	Organization and Qualification	  	 	6	  
	 4.2
	 	Authority Relative to this Agreement; Non-Contravention	  	 	7	  
	 4.3
	 	No Conflicts	  	 	7	  
	 4.4
	 	Capitalization	  	 	7	  
	 4.5
	 	Validity of the Shares	  	 	8	  
	 4.6
	 	Exchange Act Reports; Financial Statements	  	 	8	  
	 4.7
	 	Litigation	  	 	9	  
	 4.8
	 	No Brokers or Finders	  	 	9	  
	 4.9
	 	Tax Matters	  	 	9	  
	 4.10
	 	Contracts and Commitments	  	 	11	  
	 4.11
	 	Affiliate Transactions	  	 	11	  
	 4.12
	 	Compliance with Laws; Permits	  	 	11	  
	 4.13
	 	Books and Records	  	 	12	  
	 4.14
	 	Real Property	  	 	12	  
	 4.15
	 	Insurance	  	 	12	  
	 4.16
	 	No Undisclosed Liabilities	  	 	12	  
	 4.17
	 	Environmental Matters	  	 	12	  
	 4.18
	 	Absence of Certain Developments	  	 	12	  
	 4.19
	 	Employee Benefit Plans	  	 	13	  
	 4.20
	 	Employees	  	 	13	  
	 4.21
	 	Proprietary Information and Inventions	  	 	13	  
	 4.22
	 	Intellectual Property	  	 	14	  

  
 i 

							
	 4.23
	 	Investment Company	  	 	14	  
	 4.24
	 	Foreign Corrupt Practices	  	 	14	  
	 4.25
	 	No Integrated Offering	  	 	14	  
	 4.26
	 	Application of Takeover Provisions	  	 	14	  
	 4.27
	 	Information	  	 	15	  
	 4.28
	 	Full Disclosure	  	 	15	  
		
	 Article V ADDITIONAL COVENANTS AND AGREEMENTS
	  	 	15	  
			
	 5.1
	 	Further Assurances; Governmental Filings	  	 	15	  
	 5.2
	 	Expenses	  	 	15	  
	 5.3
	 	Private Placement	  	 	15	  
		
	 Article VI CONDITIONS
	  	 	16	  
			
	 6.1
	 	Conditions to Obligation of the Company	  	 	16	  
	 6.2
	 	Conditions to Obligation of Buyer	  	 	16	  
		
	 Article VII GENERAL PROVISIONS
	  	 	18	  
			
	 7.1
	 	Notices	  	 	18	  
	 7.2
	 	No Survival	  	 	19	  
	 7.3
	 	Interpretation	  	 	19	  
	 7.4
	 	Severability	  	 	19	  
	 7.5
	 	Amendment	  	 	20	  
	 7.6
	 	Waiver	  	 	20	  
	 7.7
	 	Miscellaneous	  	 	20	  
	 7.8
	 	Counterparts; Facsimile Signatures	  	 	20	  
	 7.9
	 	Third Party Beneficiaries	  	 	20	  
	 7.10
	 	Governing Law	  	 	20	  
	 7.11
	 	Jurisdiction; Service of Process	  	 	20	  
	 7.12
	 	Waiver of Jury Trial	  	 	20	  
	 7.13
	 	Disclosure in Schedules	  	 	21	  

 SCHEDULES 

Schedule 4.4(b) — Holders of Company Common Stock 

Schedule 4.8 — Brokers and Finders 

  
 ii 

 STOCK PURCHASE AGREEMENT 

This Stock Purchase Agreement (this “Agreement”) is entered into as of October 31, 2013, by and between Zosano, Inc., a
Delaware corporation formerly named Eco Planet Corp. (the “Company”), and ZP Holdings, Inc., a Delaware corporation (“Buyer”). 

In consideration of the representations, warranties and covenants contained herein, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 ARTICLE I 

DEFINITIONS 
 As used
herein, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined): 

“Affiliate” shall have the meaning ascribed to such term in Rule 12b-2 promulgated under the Exchange Act, as such regulation
is in effect on the date hereof. 
 “Amended and Restated Term Sheet” shall have the meaning set forth in
Section 2.1(b). 
 “Board of Directors” shall mean the board of directors of the entity specified. 

“Closing” shall have the meaning set forth in Section 2.2. 

“Closing Date” shall have the meaning set forth in Section 2.2. 

“Code” shall mean the Internal Revenue Code of 1986, as amended. 

“Company Charter Amendments” shall mean, collectively, the Amended and Restated Certificate of Incorporation of the Company
filed with the Secretary of State of the State of Delaware on September 24, 2013, the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of the State of Delaware on
October 1, 2013, the Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of the State of Delaware on October 11, 2013, and the Certificate of Amendment to Amended
and Restated Certificate of Incorporation of the Company filed with the Secretary of State of the State of Delaware on October 17, 2013. 

“Company Common Stock” shall have the meaning set forth in Section 2.1(a). 

“Company Financial Statements” shall have the meaning set forth in Section 4.6(c). 

“Company Form S-1” shall have the meaning set forth in Section 4.6(a). 

“Company Insiders” shall have the meaning set forth in Section 4.11. 

“Company Latest Balance Sheet” shall have the meaning set forth in Section 4.16. 

 “Company SEC Filings” shall have the meaning set forth in Section 4.6(a).

 “Compensatory Plan” shall mean (i) any employment, consulting, noncompetition, nondisclosure, nonsolicitation,
severance, termination, pension, retirement, supplemental retirement, excess benefit, profit sharing, bonus, incentive, deferred compensation, retention, change in control or similar plan, program, arrangement, agreement, policy or commitment,
(ii) any compensatory equity interest, stock option, restricted stock, deferred stock, performance stock, stock appreciation, stock unit or other equity or equity-based plan, program, arrangement, agreement, policy or commitment, (iii) any
savings, life, health, disability, accident, medical, dental, vision, cafeteria, insurance, flex spending, adoption/dependent/employee assistance, tuition, vacation, paid-time-off, other welfare fringe benefit or other employee compensation plan,
program, arrangement, agreement, policy or commitment, including any “employee benefit plan” as defined in Section 3(3) of ERISA, and (iv) any trust, escrow, funding, insurance or other agreement related to any of the foregoing,
in each case, to, under or with respect to which the Company has any actual or contingent obligation or liability. 

“ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended, or any successor law and the rules and
regulations promulgated thereunder. 
 “ERISA Affiliate” shall mean any entity which is (or at any relevant time was), with
the Company, a member of a “controlled group of corporations,” under “common control” with, or a member of an “affiliated service group,” within the meaning of Section 414(b), (c), (m) or (o) of the Code.

 “Escrow Agreement No. 1” shall mean that certain Escrow Agreement dated as of July 23, 2013 by and among the
Company, Buyer and Anslow & Jaclin, LLP, as escrow agent, as amended by Amendment No. 1 to Escrow Agreement dated as of September 17, 2013 by and among the Company, Buyer and Szaferman Lakind Blumstein & Blader, PC, as
successor escrow agent. 
 “Escrow Agreement No. 2” shall mean that certain Escrow Agreement dated as of
October 21, 2013 by and among the Company, Buyer and Szaferman Lakind Blumstein & Blader, PC, as escrow agent. 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, including the rules and regulations promulgated
thereunder. 
 “Final Deposit” shall have the meaning set forth in Section 2.1(b). 

“GAAP” shall mean United States generally accepted accounting principles, as in effect from time to time. 

“Initial Deposit” shall have the meaning set forth in Section 2.1(b). 

“Knowledge” shall mean, with respect to an individual, that such individual is actually aware of a particular fact or other
matter, with no obligation to conduct any inquiry or other investigation to determine the accuracy of such fact or other matter. A Person other than an individual shall be deemed to have Knowledge of a particular fact or other matter if the
officers, 

  
 2 

 
directors or other management personnel of such Person had Knowledge of such fact or other matter. 

“Material Adverse Effect” shall mean, with respect to an entity, a material adverse effect on the business, operations,
results of operations or financial condition of such entity on a consolidated basis. 
 “Original Term Sheet” shall have
the meaning set forth in Section 2.1(b). 
 “Person” shall mean any individual, corporation (including any non-profit
corporation), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, labor union, governmental authority or other entity. 

“Purchase Price” shall have the meaning set forth in Section 2.1(a). 

“Requisite Company Stockholder Vote” shall have the meaning set forth in Section 4.2. 

“Returns” shall have the meaning set forth in Section 4.9(a). 

“SEC” shall mean the United States Securities and Exchange Commission. 

“Securities Act” shall mean the Securities Act of 1933, as amended, including the rules and regulations promulgated
thereunder. 
 “Shares” shall have the meaning set forth in Section 2.1(a). 

“Subsidiary” shall mean, with respect to any Person, (i) each corporation of which such Person owns directly or
indirectly fifty percent (50%) or more of the voting securities and (ii) any other Person of which such Person owns at least a majority voting interest, and shall, in each case, unless otherwise indicated, be deemed to refer to both direct
and indirect subsidiaries of such Person. 
 “Tax” or “Taxes” (and, with correlative meaning,
“Taxable” and “Taxing”) shall mean any federal, state, local or foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, property or windfall profits taxes,
environmental taxes, customs duties, capital stock, franchise, employees’ income withholding, foreign or domestic withholding, social security, unemployment, disability, workers’ compensation, employment-related insurance, real property,
personal property, sales, use, transfer, value added, alternative or add-on minimum or other governmental tax, fee, assessment or charge of any kind whatsoever including any interest, penalties or additions to any Tax or additional amounts in
respect of the foregoing. 
 ARTICLE II 

PURCHASE AND SALE OF COMMON STOCK 

2.1 Sale and Issuance of Common Stock. 

  
 3 

 (a) Subject to the terms and conditions of this Agreement, Buyer agrees to purchase at the
Closing, and the Company agrees to sell and issue to Buyer at the Closing, 10,016,973 shares of the common stock, $0.0001 par value per share, of the Company (the “Company Common Stock”), for an aggregate purchase price of $365,000
(the “Purchase Price”). The shares of Company Common Stock issued to Buyer pursuant to this Agreement shall be referred to in this Agreement as the “Shares.” At the Closing, the Company shall deliver to Buyer a
certificate representing the Shares against payment of the Purchase Price, in accordance with Section 2.1(b). 
 (b) The Company and
Buyer acknowledge and agree that the Company has, (i) pursuant to the Term Sheet dated July 23, 2013 between the Company and Buyer, as amended by Amendment No. 1 to Term Sheet dated as of September 17, 2013 between the Company
and Buyer (as so amended, the “Original Term Sheet”), paid the Company a cash deposit in respect of the Purchase Price in the amount of $140,000 (the “Initial Deposit”), and (ii) pursuant to the Amended and
Restated Term Sheet dated October 21, 2013 between the Company and Buyer (the “Amended and Restated Term Sheet”), paid the Company a cash deposit in respect of the Purchase Price in the amount of $225,000 (the “Final
Deposit”). The Company and Buyer further acknowledge and agree that the Initial Deposit has been released to the Company prior to the date of this Agreement pursuant to the terms of Escrow Agreement No. 1 and shall be credited against
the Purchase Price, and that the Final Deposit will be released to the Company upon the Closing pursuant to the terms of Escrow Agreement No. 2 and shall be credited against the Purchase Price. Accordingly, and for the avoidance of doubt,
Buyer’s obligations to the Company in respect of the Purchase Price are hereby deemed fully paid, discharged and satisfied, and Buyer shall not be obligated to pay any additional amount to the Company in respect of the Purchase Price for the
Shares. 
 2.2 Closing. Subject to the provisions of Article VI, the closing of the purchase and sale of the Shares (the
“Closing”) shall take place or remotely via the exchange of documents and signatures on the date of this Agreement, or at such other time and/or place as the Company and Buyer mutually agree upon. As used herein, the term
“Closing Date” shall mean the date on which the Closing occurs. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF BUYER 

Buyer hereby represents and warrants to the Company as follows: 

3.1 Organization and Qualification. Buyer is, and on the Closing Date will be, a corporation duly organized, validly existing and in
good standing under the laws of the State of Delaware, and has, and on the Closing Date will have, the requisite corporate power to carry on its business as now conducted. Buyer is, and on the Closing Date will be, licensed or qualified to do
business in every jurisdiction in which the nature of its business or its ownership of property requires it to be licensed or qualified, except where the failure to be so licensed or qualified would not have a Material Adverse Effect on Buyer. 

3.2 Authority Relative to this Agreement; Non-Contravention. Buyer has the requisite corporate power and authority to enter into
this Agreement and to carry out its 

  
 4 

 
obligations hereunder. The execution and delivery of this Agreement by Buyer and the consummation by Buyer of the transactions contemplated hereby have been duly authorized by all necessary
corporate proceedings on the part of Buyer. This Agreement has been duly executed and delivered by Buyer and, assuming it is a valid and binding obligation of the Company, constitutes a valid and binding obligation of Buyer enforceable in accordance
with its terms, except as enforcement may be limited by general principles of equity, whether applied in a court of law or a court of equity, and by bankruptcy, insolvency and similar laws affecting creditors’ rights and remedies generally. No
authorization, consent or approval of, or filing with, any public body, court or authority is necessary on the part of Buyer for the consummation by Buyer of the transactions contemplated by this Agreement, except for such authorizations, consents,
approvals and filings as to which the failure to obtain or make the same would not, in the aggregate, reasonably be expected to have a Material Adverse Effect on Buyer, or adversely affect the consummation of the transactions contemplated hereby.

 3.3 No Conflicts. Buyer is not subject to, or obligated under, any provision of (a) its certificate of incorporation or
bylaws, (b) any agreement, arrangement or understanding, (c) any license, franchise or permit or (d) any law, regulation, order, judgment or decree, which would conflict with, be breached or violated, or in respect of which a right of
termination or acceleration or any security interest, charge or encumbrance on any of its assets would be created, by the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby, other than
any such conflicts, breaches, violations, rights of termination or acceleration or security interests, charges or encumbrances for which consents or waivers have been obtained or which, in the aggregate, would not reasonably be expected to result in
a Material Adverse Effect on Buyer. 
 3.4 Purchase for Own Account. This Agreement is made with Buyer in reliance upon Buyer’s
representation to the Company, which by Buyer’s execution of this Agreement Buyer hereby confirms, that the Shares to be acquired by Buyer will be acquired for investment for Buyer’s own account, not as a nominee or agent, and not with a
view to the resale or distribution of any part thereof, and that Buyer has no present intention of selling, granting any participation in, or otherwise distributing the same. By executing this Agreement, Buyer further represents that Buyer does not
presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Shares. Buyer has not been formed for the specific purpose
of acquiring the Shares. 
 3.5 Disclosure of Information. Buyer has had an opportunity to discuss the Company’s business,
management, financial affairs and the terms and conditions of the offering of the Shares with the Company’s management. The foregoing, however, does not limit or modify the representations and warranties of the Company in Article IV of this
Agreement or the right of Buyer to rely thereon. 
 3.6 Restricted Securities. Buyer understands that the Shares have not been, and
will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act. Buyer understands that the Shares are “restricted securities” under applicable U.S. federal and
state securities laws and that, pursuant to these laws, Buyer must hold the Shares indefinitely unless they are registered with the SEC and 

  
 5 

 
qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Shares will not be transferable except (1) pursuant to an effective
registration statement under the Securities Act or (2) upon receipt by the Company of a written opinion of counsel for the holder reasonably satisfactory to the Company to the effect that the proposed transfer is exempt from the registration
requirements of the Securities Act and applicable state securities laws. Buyer acknowledges that the Company has no obligation to register or qualify the Shares for resale. Buyer further acknowledges that if an exemption from registration or
qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and on requirements relating to the Company which are outside of Buyer’s
control, and which the Company is under no obligation and may not be able to satisfy. Buyer understands that restrictive legends shall be placed on all certificates representing the Shares, substantially as follows: 

“NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE MADE
EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS IN EFFECT THEREUNDER AND ALL APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS (SUCH FEDERAL AND STATE
LAWS, THE “SECURITIES LAWS”) OR (B) IF THE CORPORATION HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL SHALL BE REASONABLY SATISFACTORY TO THE CORPORATION, TO THE EFFECT THAT SUCH TRANSFER,
SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION IS EXEMPT FROM THE PROVISIONS OF THE SECURITIES LAWS.” 
 3.7
Accredited Investor. Buyer is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. 

3.8 No General Solicitation. Neither Buyer nor any of its officers, directors, employees, agents or stockholders has either directly or
indirectly, including through a broker or finder, engaged in any general solicitation or published any advertisement in connection with the offer and sale of the Shares. 

ARTICLE IV 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company hereby represents and warrants to Buyer as follows: 

4.1 Organization and Qualification. The Company is, and on the Closing Date will be, a corporation duly organized, validly existing and
in good standing under the laws of the State of Delaware, and has, and on the Closing Date will have, the requisite corporate power to carry on its business as now conducted. The copies of the certificate of incorporation and bylaws of the Company
that have been made available to Buyer on or prior to the date of this Agreement are correct and complete copies of such documents as in effect as of the date hereof, and shall be in effect on the Closing Date. The Company is, and on the Closing
Date will be, licensed or 

  
 6 

 
qualified to do business in every jurisdiction in which the nature of its business or its ownership of property requires it to be licensed or qualified, except where the failure to be so licensed
or qualified would not have a Material Adverse Effect on the Company, individually or in the aggregate. 
 4.2 Authority Relative to this
Agreement; Non-Contravention. The Company has the requisite corporate power and authority to enter into this Agreement and to carry out its obligations hereunder. The execution and delivery of this Agreement by the Company and the consummation
by the Company of the transactions contemplated hereby have been duly authorized by the Board of Directors of the Company and by the affirmative vote of the holders of a majority of the issued and outstanding shares of Company Common Stock (the
“Requisite Company Stockholder Vote”), and no other corporate proceedings on the part of the Company are necessary to authorize the execution and delivery of this Agreement and the consummation of the transactions contemplated
hereby, or will otherwise be sought by the Company. This Agreement has been duly executed and delivered by the Company and, assuming it is a valid and binding obligation of Buyer, constitutes a valid and binding obligation of the Company enforceable
in accordance with its terms, except as enforcement may be limited by general principles of equity, whether applied in a court of law or a court of equity, and by bankruptcy, insolvency and similar laws affecting creditors’ rights and remedies
generally. Except for approvals under applicable Blue Sky laws and the filing of Form D with the SEC, no authorization, consent or approval of, or filing with, any public body, court or authority is necessary on the part of the Company for the
consummation by the Company of the transactions contemplated by this Agreement, except for such authorizations, consents, approvals and filings as to which the failure to obtain or make the same would not, in the aggregate, reasonably be expected to
have a Material Adverse Effect on the Company or adversely affect the consummation of the transactions contemplated hereby. 
 4.3 No
Conflicts. The Company is not subject to, or obligated under, any provision of (a) its certificate of incorporation or bylaws, (b) any agreement, arrangement or understanding, (c) any license, franchise or permit, or
(d) subject to obtaining the approvals referred to in Section 4.2, any law, regulation, order, judgment or decree which would conflict with, be breached or violated, or in respect of which a right of termination or acceleration or any
security interest, charge or encumbrance on any of their respective assets would be created, by the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby, other than any such conflicts,
breaches, violations, rights of termination or acceleration or security interests, charges or encumbrances which, in the aggregate, would not reasonably be expected to have a Material Adverse Effect on the Company. 

4.4 Capitalization. 
 (a)
As of the date hereof, the Company is, and as of immediately prior to the Closing will be, authorized to issue 195,000,000 shares of Company Common Stock and 5,000,000 shares of preferred stock, $0.0001 par value per share, of which 10,027 shares of
Company Common Stock and no shares of preferred stock are and will be issued and outstanding. The issued and outstanding shares of capital stock of the Company are, and at the Closing will be, duly authorized, validly issued, fully paid and
nonassessable, not issued in violation of any preemptive rights or any applicable law, and free from any restrictions on 

  
 7 

 
transfer (other than restrictions under the Securities Act or state securities laws) or any option, lien, pledge, security interest, encumbrance, restriction or charge of any kind. Other than the
Company Common Stock, the Company does not have, and at the Closing will not have, any other securities, including equity securities, securities containing any equity features or debt securities, authorized, issued or outstanding. The Company has
not at any time granted any stock options, restricted stock, restricted stock units, phantom stock, performance stock or other compensatory equity or equity-linked awards. There are no commitments, obligations, agreements or other rights or
arrangements existing which provide for the sale or issuance of capital stock by the Company and there are no rights, subscriptions, warrants, options, conversion rights or agreements of any kind outstanding to purchase or otherwise acquire from the
Company any shares of capital stock or other securities of the Company of any kind, and there will not be any of the foregoing prior to or at the Closing. There are, and at the Closing there will be, no arrangements, commitments, agreements or other
obligations (contingent or otherwise) which may require the Company to repurchase or otherwise acquire any shares of its capital stock. 

(b) Schedule 4.4(b) contains a list, certified by the Company’s transfer agent and registrar, of the names of the owners of record
as of the date of this Agreement of all issued and outstanding shares of Company Common Stock and the number of shares of Company Common Stock each of them holds. 

(c) The Company does not have any Subsidiaries. The Company does not own, and is not party to any contract to acquire, any equity securities or
other securities of any Person or any direct or indirect equity or ownership interest in any other Person. The Company is not a party to, and, to the Company’s Knowledge, there do not exist, any voting trusts, proxies, or other contracts with
respect to the voting of shares of capital stock of the Company. 
 4.5 Validity of the Shares. The Shares, when issued, sold and
delivered to Buyer pursuant to and in accordance with the terms and for the consideration set forth in this Agreement, will be duly authorized, validly issued, fully paid and nonassessable and free of preemptive rights and liens, claims or
encumbrances or any kind whatsoever, other than restrictions on transfer under applicable state and federal securities laws. Assuming the accuracy of the representations of Buyer in Article III and subject to the filing of Form D with the SEC
pursuant to Regulation D of the Securities Act and filings pursuant to applicable state securities laws, the Shares will be issued in compliance with all applicable federal and state securities laws. 

4.6 Exchange Act Reports; Financial Statements. 

(a) The Company has never filed a registration statement under the Exchange Act and has never registered any class of equity security under the
Exchange Act. Since the filing of the Company’s Registration Statement on Form S-1 on May 2, 2012 (the “Company Form S-1”), the Company has timely filed all reports, forms and documents that it was required to file with
the SEC pursuant to the Exchange Act (such reports, forms and documents, together with the Company Form S-1 and any reports, forms and documents voluntarily filed by the Company with the SEC under the Exchange Act since the date of the Company Form
S-1, the “Company SEC Filings”). As of their respective filing dates (or if amended or superseded by a subsequent filing prior to the date of this Agreement, on the date of such amending or

  
 8 

 
superseding filing), each of the Company SEC Filings (i) did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading and (ii) complied as to form in all material respects with the Exchange Act and the applicable rules and regulations of the SEC promulgated
thereunder. 
 (b) The Company has timely filed (or has been deemed to have timely filed pursuant to Rule 12b-25 under the Exchange Act) and
made publicly available on the SEC’s EDGAR system, and Buyer may rely upon, all certifications and statements required by (i) Rule 13a-14 or Rule 15d-14 under the Exchange Act and (ii) Section 906 of the Sarbanes Oxley Act of
2002 with respect to any documents filed with the SEC. Since the most recent filing of such certifications and statements, there have been no significant changes in the Company’s internal control over financial reporting (as such term is
defined in Rule 13a-15(f) under the Exchange Act), or in other factors that could significantly affect its disclosure controls and procedures. 

(c) The financial statements (including footnotes thereto) included in or incorporated by reference into the Company SEC Filings (the
“Company Financial Statements”) were complete and correct in all material respects as of their respective filing dates, complied as to form in all material respects with the Exchange Act and the applicable accounting requirements,
rules and regulations of the SEC promulgated thereunder as of their respective dates and have been prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as otherwise noted therein). The Company Financial
Statements fairly present the financial condition of the Company as of the dates thereof and the results of operations, cash flows and stockholders’ equity of the Company for the periods referred to therein (subject, in the case of unaudited
Company Financial Statements, to normal recurring year-end adjustments). There has been no change in the Company’s accounting policies except as described in the notes to the Company Financial Statements. 

4.7 Litigation. There are no actions, suits, proceedings, orders or investigations pending or, to the Knowledge of the Company,
threatened against the Company or any of the Company’s officers, directors or employees, individually or in the aggregate, at law or in equity, or before or by any federal, state or other governmental department, court, commission, board,
bureau, agency or instrumentality, domestic or foreign, and, to the Knowledge of the Company, there is no reasonable basis for any proceeding, claim, action or governmental investigation directly or indirectly involving the Company or any of the
Company’s officers, directors or employees, individually or in the aggregate. The Company is not a party to any order, judgment or decree issued by any federal, state or other governmental department, court, commission, board, bureau, agency or
instrumentality, domestic or foreign. 
 4.8 No Brokers or Finders. Except as set forth on Schedule 4.8, none of the Company
or any of its officers, directors, employees or Affiliates has employed any broker, finder, investment banker or investment advisor or Person performing a similar function, or incurred or will incur any liability for brokerage commissions,
finders’ fees, investment advisory fees or similar compensation, in connection with the transactions contemplated by this Agreement. 

4.9 Tax Matters. 

  
 9 

 (a)  (i) The Company has timely filed (or has had timely filed on its behalf) all
returns, declarations, reports, estimates, information returns, and statements, including any schedules and amendments to such documents, required to be filed by it in respect of any Taxes (“Returns”); (ii) all such Returns are
complete and accurate in all material respects; (iii) the Company has timely paid (or has had timely paid on its behalf) all Taxes required to have been paid by it (whether or not shown on any Return); (iv) the Company has established on
the Company Latest Balance Sheet, in accordance with GAAP, reserves that are adequate for the payment of any Taxes not yet paid; and (v) the Company has complied with all applicable laws, rules and regulations relating to the collection or
withholding of Taxes from third parties (including employees) and the payment thereof (including withholding of Taxes under Sections 1441 and 1442 of the Code, or similar provisions under any foreign laws). 

(b) There are no liens for Taxes upon any assets of the Company, except statutory liens for current Taxes not yet due. 

(c) No deficiency for any Taxes has been asserted, assessed or proposed against the Company that has not been finally resolved. No waiver,
extension or comparable consent given by the Company regarding the application of the statute of limitations with respect to any Taxes or Returns is outstanding, nor is any request for any such waiver or consent pending. There is no pending or
threatened Tax audit or other administrative proceeding or court proceeding with regard to any Taxes or Returns, nor is any such Tax audit or other proceeding pending, nor has there been any notice to the Company by any Taxing authority regarding
any such Tax audit or other proceeding, or, to the Knowledge of the Company, is any such Tax audit or other proceeding threatened with regard to any Taxes or Returns. The Company does not expect the assessment of any additional Taxes of the Company
for any period prior to the date hereof and has no Knowledge of any unresolved questions, claims or disputes concerning the liability for Taxes of the Company which would exceed the estimated reserves established on its books and records. 

(d) Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby, either alone or in
combination with any other event (whether contingent or otherwise), will result in any “parachute payment” under Section 280G of the Code (or any corresponding provision of state, local, or foreign Tax law). 

(e) There is no contract, agreement, plan or arrangement to which the Company is a party which requires the Company to pay a Tax gross-up,
equalization or reimbursement payment to any Person, including with respect to any Tax-related payments under Section 409A of the Code or Section 280G of the Code. 

(f) The Company is not liable for Taxes of any other Person under Treasury Regulations section 1.1502-6 or any similar provision of state,
local or foreign Tax law, as a transferee or successor, by Contract or otherwise. The Company is not a party to any Tax sharing, allocation or indemnification agreement. The Company has not agreed, nor is the Company required, as a result of a
change in method of accounting or otherwise, to include any adjustment under Section 481 of the Code (or any corresponding provision of state, local or foreign law) in Taxable income. The Company will not be required to include any item of
income in Taxable income for any Taxable period (or portion thereof) ending after the Closing 

  
 10 

 
Date as a result of any (i) prepaid amount received on or prior to the Closing Date or (ii) “closing agreement” described in Section 7121 of the Code (or any similar or
corresponding provision of any other Tax law). No claim has ever been made by a Taxing authority in a jurisdiction where the Company does not file a Return that the Company is subject to Tax imposed by that jurisdiction. There are no advance rulings
in respect of any Tax pending or issued by any Taxing authority with respect to any Taxes of the Company. 
 (g) The Company has not been a
“distributing corporation” nor a “controlled corporation” (within the meaning of Section 355 of the Code) in a distribution of stock qualifying for tax-free treatment under Section 355 of the Code. 

(h) The Company has not requested any extension of time within which to file any Return, which return has not since been filed. 

4.10 Contracts and Commitments. Except as contemplated herein, the Company is not a party to any contract, agreement, arrangement or
other understanding, whether written or oral, which is currently in effect, and which relates to the Company or its business. 
 4.11
Affiliate Transactions. No officer, director or employee of the Company, or any member of the immediate family of any such officer, director or employee, or any entity in which any of such persons owns any beneficial interest (other than any
publicly-held corporation whose stock is traded on a national securities exchange or in an over-the-counter market and less than one percent (1%) of the stock of which is beneficially owned by any of such persons) (collectively “Company
Insiders”), has any agreement with the Company or any interest in any property, real, personal or mixed, tangible or intangible, used in or pertaining to the business of the Company. The Company is not indebted to any Company Insider for
any amounts and no Company Insider is indebted to the Company for any amounts. No Company Insider has any direct or indirect interest in any competitor, supplier or customer of the Company or in any Person from whom or to whom the Company leases any
property, or in any other Person with whom the Company transacts business of any nature. For purposes of this Section 4.11, the members of the immediate family of an officer, director or employee shall consist of the spouse, parents, children
or siblings of such officer, director or employee. 
 4.12 Compliance with Laws; Permits. 

(a) The Company and its officers, directors, agents and employees have complied in all material respects with all applicable laws, regulations
and other requirements, including federal, state, local and foreign laws, ordinances, rules, regulations and other requirements, including those pertaining to equal employment opportunity, employee retirement, affirmative action and other hiring
practices, occupational safety and health, workers’ compensation, unemployment and building and zoning codes, and no claims have been filed against the Company or any of its officers, directors, agents or employees, and the Company has not
received any notice, alleging a violation of any such laws, regulations or other requirements. The Company is not relying on any exemption from or deferral of any such applicable law, regulation or other requirement that would not be available to
Buyer after it acquires the Company’s properties, assets and business. 

  
 11 

 (b) The Company has no licenses, permits or certificates from federal, state, local or foreign
authorities (including federal and state agencies regulating occupational health and safety), and none are necessary or material to its operations and business. 

4.13 Books and Records. The books of account, minute books, stock record books and other records of the Company, complete copies of
which have been made available to Buyer, have been properly kept and contain no inaccuracies except for inaccuracies that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company. At the
Closing, all of the Company’s records will be in the possession of the Company or its counsel. 
 4.14 Real Property. The
Company does not own, lease or use any real property. 
 4.15 Insurance. The Company does not own or maintain any insurance policies.

 4.16 No Undisclosed Liabilities . Except as reflected in the unaudited balance sheet of the Company as of June 30, 2013
included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended on such date (the “Company Latest Balance Sheet”), the Company has no liabilities (whether accrued, absolute, contingent, unliquidated or
otherwise) including any liabilities which have arisen after the date of the Company Latest Balance Sheet in the ordinary course of business or liabilities to its directors, officers and employees. 

4.17 Environmental Matters. None of the operations of the Company involves the generation, transportation, treatment, storage or
disposal of hazardous waste, as defined under 40 C.F.R. Parts 260-270, or any state, local or foreign equivalent. 
 4.18 Absence of
Certain Developments. Except as disclosed in the Company SEC Filings or as otherwise contemplated by this Agreement, since the date of the Company Latest Balance Sheet, the Company has conducted its business only in the ordinary course
consistent with past practice and there has not occurred or been entered into, as the case may be: (i) any event having a Material Adverse Effect on the Company, (ii) any event that would reasonably be expected to prevent or materially
delay the performance of the Company’s obligations pursuant to this Agreement, (iii) any material change by the Company in its accounting methods, principles or practices, (iv) any declaration, setting aside or payment of any dividend
or distribution in respect of the shares of capital stock of the Company or any redemption, purchase or other acquisition of any of the Company’s securities, other than the special dividend referred to in Section 6.2(g), (v) any
increase in the compensation or benefits payable or to become payable to any officers or directors of the Company or establishment or modification of any Compensatory Plan, (vi) any issuance, grant or sale of any stock, options, warrants,
notes, bonds or other securities, or entry into any agreement with respect thereto by the Company, (vii) any amendment to the certificate of incorporation or bylaws of the Company, other than the Company Charter Amendments, (viii) any
(w) capital expenditures by the Company, (x) purchase, sale, assignment or transfer of any material assets by the Company, (y) mortgage, pledge or existence of any lien, encumbrance or charge on any material assets or properties,
tangible or intangible, of the Company, except for liens for Taxes not yet due, or (z) cancellation, compromise, release or waiver by the Company of any rights of material value or any material debts or claims, (ix) any incurrence by the
Company of any material liability (absolute or 

  
 12 

 
contingent), except for current liabilities and obligations incurred in the ordinary course of business consistent with past practice (which liabilities are not material, individually or in the
aggregate, and will have been paid, discharged and satisfied at or prior to the Closing), (x) damage, destruction or similar loss, whether or not covered by insurance, materially affecting the business or properties of the Company,
(xi) entry by the Company into any agreement, contract, lease or license, other than the Original Term Sheet, Escrow Agreement No. 1, the Amended and Restated Term Sheet and Escrow Agreement No. 2, (xii) any acceleration,
termination, modification or cancellation of any agreement, contract, lease or license to which the Company is a party or by which any of them is bound, (xiii) entry by the Company into any loan or other transaction with any officers, directors
or employees of the Company, (xiv) any charitable or other capital contribution by the Company or pledge therefore, (xv) entry by the Company into any transaction of a material nature or (xvi) any negotiation or agreement by the
Company to do any of the things described in the preceding clauses (i) through (xv). 
 4.19 Employee Benefit Plans. 

(a) The Company does not sponsor, maintain or have any obligation or liability under, or has not at any time sponsored, maintained or had any
obligation or liability under, any Compensatory Plan. Without limiting the generality of the foregoing, neither the Company nor any ERISA Affiliate sponsors, maintains or has any obligation or liability under, or has sponsored, maintained or had any
obligation or liability under, any (i) “multiemployer plan” (within the meaning of Section 3(37) of ERISA), or (ii) single employer plan or other pension plan subject to Title IV or Section 302 of ERISA or
Section 412 of the Code. The Company and its ERISA Affiliates are in compliance in all material respects with the applicable requirements of Section 4980B of the Code and any similar state law. 

(b) Neither the execution of this Agreement nor the consummation of the transactions contemplated by this Agreement shall, individually or in
the aggregate, (i) result in any payment becoming due to any officer, employee, consultant or director of the Company, (ii) increase or modify any benefits otherwise payable by the Company to any officer, employee, consultant or director
of the Company or (iii) result in the acceleration of time of payment or vesting of any such benefits. 
 4.20 Employees. Except
as disclosed in the Company SEC Filings, the Company does not have any employees and does not have any obligation or liability to any current or former officer, director, employee or Affiliate of the Company for wages, accrued vacation or otherwise.
Each individual providing services to the Company has been properly classified as an employee or a non-employee service provider with respect to the Company for all purposes under applicable law. No current or former employee, consultant or director
of the Company owes any indebtedness to the Company or any of its Affiliates. The Company is not, and has never been, a party to any collective bargaining or similar agreement, and there are no labor unions or other organizations representing,
purporting to represent or, to the Knowledge of the Company, attempting to represent, any employee of the Company. 
 4.21 Proprietary
Information and Inventions. No current employee of or consultant to the Company is party to either a non-disclosure and inventions assignment agreement or an 

  
 13 

 
alternative employment agreement with the Company containing comparable non-disclosure and inventions assignment provisions. 

4.22 Intellectual Property. 

(a) The Company does not own or license the right to use any patents, copyrights, trademarks, know-how or software. 

(b) The Company is not infringing upon the intellectual property or proprietary rights of any Person. There are no claims pending or, to the
Company’s Knowledge, threatened alleging that the Company is currently infringing upon, using in an unauthorized manner or violating the intellectual property or proprietary rights of any Person. 

(c) The Company is not, nor will it be as a result of the execution and delivery of this Agreement or the performance of its obligations
hereunder, in breach of any license, sublicense or other agreement or contract relating to intellectual property or proprietary rights that would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect on the
Company. 
 4.23 Investment Company. The Company is not as of the date of this Agreement, nor upon the Closing will be, an
“investment company,” a company controlled by an “investment company,” or an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company,” as such terms are
defined in the Investment Company Act of 1940, as amended. 
 4.24 Foreign Corrupt Practices. None of the Company or any director,
officer or, to the knowledge of the Company, agent, employee or other Person acting on behalf of the Company, has, in the course of its actions for, or on behalf of, the Company: (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation
of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made other unlawful payment to any foreign or domestic government official or employee. 

4.25 No Integrated Offering. Neither the Company nor any Affiliates of the Company, nor any Person acting on the behalf of any of the
foregoing, has, directly or indirectly, made any offers or sales of any security or solicited any offers to purchase any security, under circumstances that would require registration under the Securities Act of any of the Shares issuable to Buyer
pursuant to this Agreement or cause such offering of Shares to be integrated with prior offerings by the Company for purposes of the Securities Act or any applicable shareholder approval requirements of any authority. 

4.26 Application of Takeover Provisions. The Company and its Board of Directors have taken all necessary action, if any, in order to
render inapplicable any control share acquisition, business combination, or other similar takeover, anti-takeover, moratorium, fair price, interested shareholder or similar provision under the certificate of incorporation of the Company or the laws
of the State of Delaware with respect to the Company’s issuance and sale of the Shares to Buyer hereunder. The Company has never adopted any shareholder rights plan 

  
 14 

 
or similar arrangement relating to accumulations of beneficial ownership of Company Common Stock or a change in control of the Company. 

4.27 Information. All of the information provided by, or on behalf of, the Company regarding the Company or any of its officers,
directors, employees, agents or other representatives, to Buyer or its representatives for purposes of, or otherwise in connection with, the preparation of any filings to be made with the SEC and any other governmental authority in connection with
the consummation of the transactions contemplated hereby is accurate and complete in all material respects. 
 4.28 Full Disclosure.
The representations and warranties of the Company contained in this Agreement (and in any schedule, exhibit, certificate or other instrument to be delivered under this Agreement) are true and correct in all material respects, and such
representations and warranties do not omit any material fact necessary to make the statements contained therein, in light of the circumstances under which they were made, not misleading. There is no fact of which the Company has Knowledge that has
not been disclosed to Buyer pursuant to this Agreement, including the schedules hereto, all taken together as a whole, which has had or would reasonably be expected to have a Material Adverse Effect on the Company or materially adversely affect the
ability of the Company to consummate in a timely manner the transactions contemplated hereby. 
 ARTICLE V 

ADDITIONAL COVENANTS AND AGREEMENTS 

5.1 Further Assurances; Governmental Filings. At any time or from time to time after the Closing, each of the parties hereto shall, at
the expense of the party making such request, execute and deliver such other documents and instruments, provide such materials and information and take such other actions as may reasonably be necessary, proper or advisable, to the extent permitted
by law, to fulfill its obligations under this Agreement. Each party will use all reasonable efforts and will cooperate with the other party in the preparation and filing, as soon as practicable, of all filings, applications or other documents
required under applicable laws, including the Exchange Act, to consummate, or otherwise in connection with, the transactions contemplated by this Agreement, including the filing with the SEC of a Form 8-K. 

5.2 Expenses. Except as otherwise provided in this Agreement, all reasonable and documented costs and expenses incurred in connection
with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such expenses. Without limiting the generality of the foregoing, any such costs and expenses incurred by the Company that remain unpaid as of the
Closing, including any liability for brokerage commissions, finders’ fees, investment advisory fees or similar compensation in connection with the transactions contemplated by this Agreement, shall be paid by the Company using the proceeds from
the sale of the Shares hereunder. 
 5.3 Private Placement. Each of Buyer and the Company shall take all necessary action on its part
such that the issuance of the Shares to Buyer hereunder constitutes a valid “private placement” under the Securities Act. 

  
 15 

 ARTICLE VI 

CONDITIONS 
 6.1
Conditions to Obligation of the Company. The obligation of the Company to issue and sell the Shares to Buyer at the Closing are subject to the fulfillment or waiver at or prior to the Closing of the following conditions: 

(a) Representations and Compliance. The representations and warranties of Buyer contained in this Agreement shall be accurate as of the
Closing in all respects (in the case of any representation or warranty containing any materiality qualification) and in all material respects (in the case of any representation or warranty not containing any materiality qualification), except for
representations and warranties made as of a specific date, which shall be accurate as of such date. Buyer shall in all material respects have performed each obligation and agreement and complied with each covenant to be performed and complied with
by it hereunder at or prior to the Closing. 
 (b) Officers’ Certificate. Buyer shall have furnished to the Company a certificate
of the President of Buyer, dated as of the Closing Date, in which such officer certifies that, to the best of his Knowledge, the conditions set forth in Section 6.1(a) have been fulfilled. 

(c) Secretary’s Certificate. Buyer shall have furnished to the Company (i) copies of the text of the resolutions by which the
corporate action on the part of Buyer necessary to approve this Agreement and the transactions contemplated hereby were taken, (ii) a certificate dated as of the Closing Date executed on behalf of Buyer by its corporate secretary or one of its
assistant corporate secretaries certifying to the Company (x) that such copies are true, correct and complete copies of such resolutions and that such resolutions were duly adopted and have not been amended or rescinded, and (y) the
signature and office of each officer of Buyer executing this Agreement or any other agreement, certificate or other instrument executed pursuant hereto by Buyer, and (iii) a certificate from the Secretary of State of the State of Delaware
evidencing the good standing of Buyer in such jurisdiction dated as of a recent date prior to the Closing Date. 
 (d) Consents and
Approvals. Buyer shall have obtained all consents and approvals necessary to purchase the Shares pursuant to this Agreement, in order that Buyer’s purchase of the Shares hereunder not constitute a breach or violation of, or result in a
right of termination or acceleration of, or the creation of any encumbrance on any of Buyer’s assets pursuant to the provisions of, any agreement, arrangement or undertaking of or affecting Buyer or any license, franchise or permit of or
affecting Buyer. 
 6.2 Conditions to Obligation of Buyer. The obligation of Buyer to purchase the Shares at the Closing is subject
to the fulfillment or waiver at or prior to the Closing of the following conditions: 
 (a) Representations and Compliance. The
representations and warranties of the Company contained in this Agreement shall be accurate as of the Closing in all respects (in the case of any representation or warranty containing any materiality qualification) and in all material respects (in
the case of any representation or warranty not containing any materiality 

  
 16 

 
qualification), except for representations and warranties made as of a specific date, which shall be accurate as of such date. The Company shall in all material respects have performed each
obligation and agreement and complied with each covenant to be performed and complied with by it hereunder at or prior to the Closing. 
 (b)
Officers’ Certificate. The Company shall have furnished to Buyer a certificate of the President of the Company, dated as of the Closing Date, in which such officer certifies that, to the best of his Knowledge, the conditions set forth in
Section 6.2(a) have been fulfilled. 
 (c) Secretary’s Certificate. The Company shall have furnished to Buyer
(i) copies of the text of the resolutions by which the corporate action on the part of the Company necessary to approve this Agreement and the transactions contemplated hereby, and the election of the directors and officers of the Company to
serve following the Closing Date (as set forth in Section 6.2(e)), were taken, (ii) a certificate dated as of the Closing Date executed on behalf the Company by its corporate secretary certifying to Buyer (x) that such copies are
true, correct and complete copies of such resolutions and that such resolutions were duly adopted and have not been amended or rescinded, and (y) the signature and office of each officer of the Company executing this Agreement or any other
agreement, certificate or other instrument executed pursuant hereto, (iii) a copy of the certificate of incorporation, as amended, of the Company, certified by the Secretary of State of the State of Delaware, and (iv) a certificate from
the Secretary of State of the State of Delaware evidencing the good standing of the Company in such jurisdiction dated as of a recent date prior to the Closing Date. 

(d) Consents and Approvals. The Company shall have obtained all consents and approvals necessary to consummate the transactions
contemplated by this Agreement, in order that the transactions contemplated hereby not constitute a breach or violation of, or result in a right of termination or acceleration of, or the creation of any encumbrance on any of the Company’s
assets pursuant to the provisions of, any agreement, arrangement or undertaking of or affecting the Company or any license, franchise or permit of or affecting the Company. 

(e) Directors and Officers. 

(i) The Board of Directors of the Company shall have taken the following actions, in compliance with applicable law, to be effective upon the
Closing: (x) elected to the Board of Directors of the Company the persons who are the directors of Buyer, assigned to such classes as designated by Buyer; and (y) appointed as the officers of the Company those persons who are the officers
of Buyer, or, in either case with regard to the foregoing clauses (x) and (y), such other persons designated by Buyer. Subject to applicable law, the Company shall have taken all action reasonably requested by Buyer, but consistent with the
certificate of incorporation and bylaws of the Company, that is reasonably necessary to effect any such election or appointment of the designees of Buyer to the Company’s Board of Directors. 

(ii) Each of the officers and directors of the Company immediately prior to the Closing shall have delivered duly executed resignations from
their positions with the Company effective upon the Closing. 

  
 17 

 (iii) For the avoidance of doubt, the provisions of this Section 6.2(e) are in addition to
and shall not limit any rights which Buyer may have as a holder or beneficial owner of shares of capital stock of the Company as a matter of law with respect to the election of directors or otherwise. The newly-appointed directors and officers of
the Company shall hold office for the term specified in, and subject to the provisions contained in, the certificate of incorporation and bylaws of the Company and applicable law. 

(f) Company Liabilities. The Company shall have no liabilities. 

(g) Special Dividend. The Company shall have declared a cash dividend on the shares of Company Common Stock as of a record date prior to
the Closing Date in an aggregate amount equal to the Purchase Price less the amount of all of the Company’s liabilities as of the Closing (it being acknowledged and agreed by the Company and Buyer that the payment of such dividend will occur as
promptly as practicable following the Closing). 
 (h) Company Charter Amendments. The Company Charter Amendments shall continue to be
in full force and effect as of the Closing. 
 (i) FIRPTA Certificate. The Company shall have delivered to Buyer a certificate, duly
executed and acknowledged, in form and substance reasonably satisfactory to Buyer and in accordance with the provisions of Treasury Regulations Section 1.1445-2(b)(2), certifying that the transactions contemplated by this Agreement are exempt
from withholding under Section 1445 of the Code. 
 ARTICLE VII 

GENERAL PROVISIONS 
 7.1
Notices. All notices and other communications hereunder shall be in writing and shall be sufficiently given if made by hand delivery, by facsimile, by nationally recognized overnight delivery service for next business day delivery, or by
registered or certified mail (return receipt requested), in each case with delivery charges prepaid, to the parties at the following addresses (or at such other address for a party as shall be specified by it by like notice): 

 

					
		 	If to Buyer:	  	 ZP Holdings, Inc.
 34790 Ardentech Court

Fremont, CA 94555
 Facsimile: (510) 952-4632

Attn: President and CEO

			
		 	with a copy to:	  	 Foley Hoag LLP
 155 Seaport Boulevard

Boston, MA 02210
 Facsimile: (617) 832-7000

Attn: Jeffrey Quillen, Esq.

  
 18 

					
		 	If to the Company:	  	 Zosano, Inc.
 93 South Jackson St., #34786

Seattle, WA 98104-2818
 Facsimile: (866) 885-5653

E-mail: info@eco-p.org
 Attn: Elka Yaron

			
		 	with a copy to:	  	 Szaferman Lakind Blumstein & Blader, PC
 101
Grovers Mill Road, Second Floor
 Lawrenceville, NJ 08648

Facsimile: (609) 557-0969
 E-mail: gjaclin@szaferman.com

Attn: Gregg Jaclin, Esq.

 All such notices and other communications shall be deemed to have been duly given as follows: (i) if
delivered by hand, when received; (ii) if delivered by registered or certified mail (return receipt requested), when receipt acknowledged; or (iii) if via facsimile, on the day of transmission or, if that day is not a business day, on the
next business day; and (iv) if delivered by a recognized overnight delivery service, on the next business day delivery after being timely delivered by the sender to such recognized overnight delivery service. 

7.2 No Survival. None of the representations, warranties, covenants and other agreements in this Agreement or in any instrument
delivered pursuant to this Agreement, including any rights arising out of any breach of any such representations, warranties, covenants or other agreements, shall survive the Closing, except for this Article VII and those covenants and agreements
herein that by their terms apply or are to be performed in whole or in part after the Closing. 
 7.3 Interpretation. The headings
contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. References to Sections and Articles refer to Sections and Articles of this Agreement unless otherwise
stated. Words such as “herein,” “hereinafter,” “hereof,” “hereto,” “hereby” and “hereunder,” and words of like import, unless the context requires otherwise, refer to this Agreement
(including the Schedules hereto). Unless the context otherwise requires, the words “include,” “includes” and “including” are deemed to be followed by “without limitation” whether or not they are followed by
such words or words of similar impart. As used in this Agreement, the masculine, feminine and neuter genders shall be deemed to include the others if the context requires. 

7.4 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be
invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties shall negotiate in
good faith to modify this Agreement and to preserve each party’s anticipated benefits under this Agreement. 

  
 19 

 7.5 Amendment. This Agreement may not be amended or modified except by an instrument in
writing approved by the parties to this Agreement and signed on behalf of each of the parties hereto. 
 7.6 Waiver. Any party hereto
may (a) extend the time for the performance of any of the obligations or other acts of the other party hereto or (b) waive compliance with any of the agreements of the other party or with any conditions to its own obligations, in each case
only to the extent such obligations, agreements and conditions are intended for its benefit. Any such extension or waiver shall only be effective if made in writing and duly executed by the party giving such extension or waiver. 

7.7 Miscellaneous. This Agreement (together with all other documents and instruments referred to herein, including Escrow Agreement
No. 1 and Escrow Agreement No. 2): (a) constitutes the entire agreement, and supersedes all other prior agreements and undertakings, both written and oral, among the parties with respect to the subject matter hereof; and
(b) shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns, but shall not be assignable by any party hereto without the prior written consent of the other parties hereto. 

7.8 Counterparts; Facsimile Signatures. This Agreement may be executed in two or more counterparts, all of which together shall
constitute a single agreement. This Agreement and any documents relating to it may be executed and transmitted to any other party by facsimile or email of a PDF, which facsimile or PDF shall be deemed to be, and utilized in all respects as, an
original, wet-inked document. 
 7.9 Third Party Beneficiaries. Each party hereto intends that this Agreement, except as expressly
provided herein, shall not benefit or create any right or cause of action in or on behalf of any person other than the parties hereto. 

7.10 Governing Law. This Agreement is governed by the internal laws of the State of Delaware without regard to such State’s
principles of conflicts of laws that would defer to the substantive laws of another jurisdiction. 
 7.11 Jurisdiction; Service of
Process. Any action or proceeding seeking to enforce any provision of, or based on any right arising out of, this Agreement must, to the extent such courts will accept such jurisdiction, be brought against any of the parties in the courts of the
State of Delaware, or, if it has or can acquire jurisdiction, in the United States District Court for the District of Delaware, and each of the parties consents to the jurisdiction of those courts (and of the appropriate appellate courts) in any
such action or proceeding and waives any objection to venue laid therein. Process in any such action or proceeding may be served by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for
the giving of notices in Section 7.1. Nothing in this Section 7.11, however, affects the right of any party to serve legal process in any other manner permitted by law. 

7.12 Waiver of Jury Trial. Each party hereby waives its rights to a jury trial of any claim or cause of action based upon or arising
out of this Agreement, the Shares or the subject matter hereof. The scope of this waiver is intended to be all-encompassing of any and all 

  
 20 

 
disputes that may be filed in any court and that relate to the subject matter of this transaction, including contract claims, tort claims, breach of duty claims, and all other common law and
statutory claims. Each party hereto hereby represents and warrants that such party has reviewed this waiver with its legal counsel, and that such party knowingly and voluntarily waives its jury trial rights following consultation with legal counsel.

 7.13 Disclosure in Schedules. For purposes of this Agreement, with respect to any matter that is clearly disclosed on any Schedule
hereto with respect to any Section hereof in such a way as to make its relevance to the information called for by another Section hereof or any other Schedule, as the case may be, reasonably apparent, such matter shall be deemed to have been
disclosed in response to such other Section or Schedule, notwithstanding the omission of any appropriate cross-reference thereto; provided, however, that each of the Company and Buyer hereby covenants to make a good faith diligent effort to
make all appropriate cross-references within and to any and all Sections of this Agreement and Schedules hereto. 
 [Remainder of Page
Left Intentionally Blank] 

  
 21 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed on the
date first written above by their respective officers. 
  

			
	ZP HOLDINGS, INC.
		
	By:	 	/s/ Vikram Lamba
		 	 Name: Vikram Lamba
 Title: President and
Chief Executive Officer

  

			
	ZOSANO, INC.
		
	By:	 	/s/ Elka Yaron
		 	 Name: Elka Yaron
 Title: President and Chief
Executive Officer

 Signature Page to Stock Purchase AgreementEX-10.17

 Exhibit 10.17 
 INVESTORS RIGHTS AGREEMENT 
 THIS INVESTORS RIGHTS AGREEMENT (this
“Agreement”) is made and entered into as of January 3, 2006, by and among Evogene Ltd., a private company organized under the laws of the State of Israel (Reg. No.: 512838723), having its registered offices at Gad
Fienshten 13 Rehovot, Israel (the “Company”) and the Company’s shareholders listed in Schedule A attached hereto (the “Shareholders”). 

R E C I T A L S 

WHEREAS the Company and each of the Shareholders listed in items 8-25 and 35-37 of Schedule A hereof are
parties to the 2nd Amended and Restated Registration
Rights Agreement dated January 11, 2004 (the “Former Amended RRA”), and certain of such Shareholders are the holders of Registrable Securities (as such term is defined therein) (the “Former RRA Registrable
Securities”) currently outstanding or issuable upon conversion of Series A Preferred Shares of the Company and/or Ordinary-1 Shares of the Company currently outstanding; and 

WHEREAS Section 2.2 of the Former Amended RRA provides that with the written consent of the Company, Compugen Ltd. and the consent
of the holders of a majority in interest of the Former RRA Registrable Securities currently outstanding or issuable upon conversion of any Series A Preferred Shares of the Company and/or Ordinary-1 Shares of the Company currently outstanding (the
“Required Majority”), the Company may amend the Former Amended RRA; and 
 WHEREAS, certain of the signatories
hereto constitute the Required Majority; and 
 WHEREAS such signatories agree to amend the Former RRA and replace it in its
entirety with this Agreement; and 
 WHEREAS the Company and the Shareholders desire to set forth certain matters regarding
registration rights and information rights, all as more fully set forth herein; and 
 WHEREAS the Company and the required
majority of those of the signatories hereto that are also parties to the Voting Agreement (as defined below) agree to its cancellation; and 
 WHEREAS the Company and the required majority of those of the signatories hereto that are also parties to the First Loan Agreement and the Second Amendment of the First Loan Agreement (both, as defined
below) agree to cancel certain provisions thereof, as further detailed herein; and 
 WHEREAS the Company and the required
majority of those of the signatories hereto that are also parties to the 2005 Convertible Bridge Loan (as defined below) agree to cancel a certain provision thereof, as further detailed herein; 

 NOW, THEREFORE, in consideration of the foregoing recitals, the mutual promises hereinafter
set forth, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
  

	1.	REGISTRATION RIGHTS 

  

	 	1.1.	In this Section 1: 

  

	 	1.1.1.	“Holder” or “Holders” shall mean the Shareholders; 

 

	 	1.1.2.	“Kadima Holder” shall mean any person or entity for which Kadima holds Registrable Securities in trust. 

 

	 	1.1.3.	“register”, “registered”, and “registration” shall refer to a registration effected by preparing and filing a
registration statement or similar document in compliance with the Securities Act or any similar or applicable securities act in a jurisdiction other than the United States, and the declaration or ordering of effectiveness of such registration
statement or document. 

  

	 	1.1.4.	“Registrable Securities” shall mean Ordinary Shares of the Company, currently held, or hereafter acquired, by the Holders, including without limitation
Ordinary Shares issuable upon conversion of the (i) Series B Preferred Shares of the Company currently outstanding or hereafter issuable pursuant to the exercise of certain warrants that have been granted to certain of the Shareholders;
(ii) Series B-1 Preferred Shares hereafter issuable pursuant to the exercise of certain warrants that have been granted to certain of the Shareholders; (iii) Series A Preferred Shares of the Company currently outstanding or hereafter
issuable pursuant to the exercise of certain warrants that have been previously granted to certain of the Shareholders; or (iv) Ordinary-1 Shares of the Company. Registrable Securities if transferred, in accordance with the Articles of
Association in effect at the time of such transfer, will remain Registrable Securities for the purpose of this Agreement. 

  

	 	1.1.5.	“Securities Act” shall mean the United States Securities Act of 1933, as amended and all regulations promulgated thereunder or under any other similar
law. 

  

	 	1.1.6.	“Series B Share Purchase Agreement” shall mean the Share Purchase Agreement made as of the 3rd day of January, 2006, by and between the
Company, Kadima High - Tech Ltd. (acting as trustee for the persons and entities listed in Schedule A attached thereto); Epione BioInvestment I L.P. and Epione BioInvestment II L.P.; and certain additional investors listed
in Schedule B attached thereto. 	 

  

	 	1.2.	Demand Registration 

  

	 	1.2.1.	 At any time upon the Initial Public Offering (IPO) of the Company and thereafter, but not more than two (2) times during the term of this
Agreement (in the aggregate, for all Holders), any Holder or group of Holders of Registrable Securities which hold an aggregate of at least 12.5% (twelve and one half percent) of the Registrable Securities of the Company then issued (the
“Initiating Holders”), may request in writing (a “Demand”) that the Company uses its best efforts to register such Holders’ Registrable Securities, or any part thereof, for trading on any recognized European or
United States securities exchange or quotation system (“Exchange”) in accordance with the provisions of 

  
 - 2 -

	 	
this Section 1.2, provided however that a Demand for registration in the United States or on any European exchange may only be effected after six (6) months from the consummation
of the Company’s initial public offering in the United States or on such European exchange and provided further that the aggregate anticipated offering price of such Registrable Securities equals at least US$4,000,000. A Demand, which
has not culminated in the registration of the requested Registrable Securities, shall not be counted as a Demand for the purposes of this section, unless the reason for such lack of culmination was due to an action of the Initiating Holders.

  

	 	1.2.2.	As soon as practicable after receipt of the Demand, the Company shall promptly give written notice of the proposed registration, qualification or compliance to all
other Holders, and shall file a registration statement covering such shares and shall take all actions under its power and control to include in such registration, qualification or compliance all Registrable Securities held by Holders who explicitly
expressed their wish to participate in such registration within twenty (20) days after receipt of the Company’s notice. Thereupon the Company shall take all reasonable actions under its power and control to effect such registration as
required and as would permit and facilitate the sale and distribution of all such portion of the Holders’ Registrable Securities as are specified in such request together with all such portion of Registrable Securities of any other Holders
joining in such request as aforesaid. 

  

	 	1.3.	Form F-3 Registration 

  

	 	1.3.1.	At any time upon the IPO of the Company and thereafter, if the Company receives from the Initiating Holders a written request that the Company effect any registration
statement on Form F-3 (or any successor form to Form F-3) for the sale of Registrable Securities, the Company shall as soon as practicable after receipt of such request give notice of proposed registration, qualification or compliance to all other
Holders and shall take all actions under its power and control to include in such registration, qualification or compliance all Registrable Securities held by Holders who explicitly expressed, in writing, their wish to participate in such
registration within twenty (20) days after receipt of the Company’s notice. Thereupon the Company shall take all actions under its power and control to effect such registration as required and as would permit and facilitate the sale and
distribution of all such portion of the Holders’ Registrable Securities as are specified in such request together with all such portion of Registrable Securities of any other Holders joining in such request as aforesaid.

  

	 	1.3.2.	The Company shall not be obligated to affect a registration, qualification or compliance pursuant to this Section 1.3 if (a) Form F-3 is not available for
such offering by the Holders, or (b) the aggregate anticipated offering price of such Registrable Securities equals less than US$2,500,000. 

  
 - 3 -

	 	1.4.	Incidental (“Piggy Back”) Registration 

  

	 	1.4.1.	If at any time, upon the IPO of the Company or thereafter, the Company shall determine to register any of its securities, either for its own account or the account of a
security holder or holders, other than registration relating solely to (a) a registration for the employee benefit plans, including stock option and stock purchase plans, (b) a registration relating solely to a Rule 145 of the Securities
Act transaction or (c) an initial public offering by the Company of its securities in which security holders of the Company do not participate as sellers, the Company will promptly give to each Holder written notice thereof and include in such
registration and in any underwriting involved therein, all the Registrable Securities specified in a written request(s) by a Holder made within twenty (20) days after receipt of the Company’s notice. 

 

	 	1.5.	The Company’s Right to Delay. The Company may delay the filing of any registration statement requested pursuant to Sections 1.2, 1.3 and 1.4, to a
date not more than hundred and twenty (120) days following the date of such request if the Company’s Board of Directors makes a determination in good faith that such a delay is necessary; provided, that the Company may not exercise such
right of delay more than once in any twelve month period. 

  

	 	1.6.	Registration Exemptions. Notwithstanding Sections 1.2 and 1.3 above, the Company shall not be obligated to take any action to effect any such
registration, qualification or compliance: 

  

	 	1.6.1.	In any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification
or compliance unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act. 

  

	 	1.6.2.	If the Company has already effected a registration pursuant to Sections 1.2 and/or 1.3 request of the Holder(s) within twelve (12) months prior to the current
requested registration pursuant to Sections 1.2 and or 1.3 above, and such registration has been declared or ordered effective. 

  

	 	1.6.3.	If, in the opinion of counsel satisfactory to the Company and the respective Holders, the sale of the Registrable Securities owned by such Holders, may then be made in
a transaction exempted from the registration and prospectus delivery requirements of the Securities Act and from the comparable requirements of the applicable state securities laws so that any transfer restrictions may be removed upon the
consummation of such sale. Any and/or all of the Kadima Holders then seeking to effect registration and for which Kadima shall at the time still hold Registrable Securities in trust, shall be treated as one block of Holders of Registrable Securities
for the purpose of this exemption. 

  
 - 4 -

	 	1.7.	Underwriting 

  

	 	1.7.1.	If a registration pursuant to Section 1.2, 1.3 or 1.4 is for a registered public offering involving an underwriting on a firm basis, the Company shall so advise
the Holders as part of the notice given pursuant to Sections 1.2, 1.3, or 1.4, as the case may be. In such event, the right of any Holder to registration pursuant to Sections 1.2, 1.3 or 1.4 shall be conditioned upon such Holder’s participation
in the underwriting arrangements as required by the applicable underwriters and this Section 1.7, and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent requested shall be limited to the extent provided
herein. The Company shall (together with all Holders proposing to distribute their securities through such underwriting) enter into an underwriting agreement with the managing underwriter selected for such underwriting by the Company. If any Holder
of Registrable Securities disapproves of the terms of the underwriting, such person may elect to withdraw therefrom by written notice to the Company, the managing underwriter and the participating Holders. 

 

	 	1.7.2.	Notwithstanding any other provision herein, if the managing underwriter advises the Holders in writing that, in such managing underwriter’s good faith professional
judgment, marketing factors require a limitation of the number of shares to be underwritten, then the number of shares of Registrable Securities that may be included in a registration pursuant to Section 1.2, 1.3 or 1.4, shall be reduced and
allocated among the Holders thereof in proportion, as nearly as practicable to the respective amounts of Registrable Securities held by such Holders at the time of filing the registration statement. No Registrable Securities excluded from the
underwriting by reason of the underwriter’s marketing limitation shall be included in such registration. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of
shares allocated to any Holder to the nearest 100 shares. 

  

	 	1.8.	State Qualification. The Company shall use its best efforts to qualify the sale of Registrable Securities to be included in any registration pursuant to
this Section 1 under the Blue Sky or other applicable laws of such jurisdictions as a Holder may reasonably request. 

  

	 	1.9.	Expenses of Registration. All registration expenses incurred in connection with any registration pursuant to this Section 1 (including up to one
counsel for the Holders) shall be borne by the Company. Unless otherwise agreed, all underwriting discounts, selling commissions and stock transfer taxes applicable to the securities registered by the Holders shall be borne by the Holders of such
securities pro rata on the basis of the number of shares so registered. 

  

	 	1.10.	Registration Procedures 

 In the case of each registration, qualification or compliance effected by the Company pursuant to this Section 1, the Company will keep each Holder advised in writing as to the initiation of each
registration, qualification and compliance and as to the completion thereof. At its expense the Company will: 
  

	 	1.10.1.	Prepare and file with the SEC a registration statement with respect to such securities and use its best efforts to cause such registration statement to become and
remain effective until the earlier of (i) three months after the effective date, or (ii) completion of the distribution described in the registration statement; and 

  
 - 5 -

	 	1.10.2.	Furnish to the Holders participating in such registration and to the underwriters of the securities being registered such reasonable number of copies of the
registration statement, preliminary prospectus, final prospectus and such other documents as such underwriters may reasonably request in order to facilitate the public offering of such securities. 

 

	 	1.11.	Indemnification 

  

	 	1.11.1.	The Company will indemnify each Holder, each of its officers and directors and partners, agents of such Holder (including its legal counsel and independent
accountants), and each person controlling such Holder within the meaning of Section 15 of the Securities Act, with respect to which registration, qualification or compliance has been effected pursuant to this Section 1, against all
expenses, claims, losses, damages or liabilities (or actions in respect thereof), including any of the foregoing incurred in settlement of any litigation, commenced or threatened, arising out of or based on any untrue statement (or alleged untrue
statement) of a material fact contained in any registration statement, prospectus, offering circular or other document, or any amendment or supplement thereto, incident to any such registration, qualification or compliance, or based on any omission
(or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or any violation by the Company of the
Securities Act or any rule or regulation promulgated under the Securities Act applicable to the Company in connection with any such registration, qualification or compliance, and the Company will reimburse each such Holder, each of its officers and
directors, and each person controlling such Holder for any legal or any other expenses reasonably incurred in connection with the investigating, preparing or defending any such claim, loss, damage, liability or action, provided that the Company will
not be liable in any such case to the extent that any such claim, loss, damage, liability or expense arises out of or is based on any untrue statement or omission or alleged untrue statement or omission, made in reliance upon and in conformity with
written information furnished to the Company by an instrument duly executed by such Holder, controlling person or underwriter and stated to be specifically for use therein. 

 

	 	1.11.2.	 Each Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration, qualification or
compliance is being effected, indemnify the Company, each of its directors and officers, agents of the Company (including its legal counsel and independent accountants), and each person who controls the Company within the meaning of Section 15
of the Securities Act, and each other such Holder, each of its officers and directors, agents of such Holder (including its legal counsel and independent accountants) 

  
 - 6 -

	 	
and each person controlling such Holder within the meaning of Section 15 of the Securities Act, against all claims, losses, damages and liabilities (or actions in respect hereof) arising out
of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such registration statement prospectus, offering circular or other document, or any omission (or alleged omission) to state therein a material fact
required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company, such other Holders, such directors, officers, persons or control persons for any legal or any other expenses reasonably
incurred in connection with investigating or defending any such claim, loss, damage, liability or action, in each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission)
is made in such registration statement, prospectus, offering circular or other document in reliance upon and in conformity with written information furnished to the Company by an instrument duly executed by such Holder and stated to be specifically
for use therein. Notwithstanding the foregoing, the liability of each Holder under this subsection 1.11.2 shall be limited in an amount equal to the initial public offering price of the shares sold by such Holder, unless such liability arises out of
or is based upon willful misconduct by such Holder. 

  

	 	1.11.3.	Each party entitled to indemnification under this Section 1.11 (the “Indemnified Party”) shall give notice to the party required to provide
indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of any such claim
or any litigation resulting therefrom and enter into any settlement thereof, subject to the Indemnified Party’s consent (which shall not be unreasonably withheld); provided that counsel for the Indemnifying Party, who shall conduct the defense
of such claim or litigation, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld), and the Indemnified Party may participate in such defense at such party’s expense, and provided further that the
failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 1.11 unless the failure to give such notice is materially prejudiced to an Indemnifying
Party’s ability to defend such action; and provided further, that the Indemnifying Party shall not assume the defense for matters as to which there is a conflict of interest or separate and different defenses in which case the Indemnified
Party’s costs of defense including reasonable fees of separate legal counsel shall be borne by the Indemnifying Party. No Indemnifying Party in the defense of any such claim or litigation shall, except with the consent of each Indemnified
Party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim
or litigation. 

  
 - 7 -

	 	1.12.	Information by Holder 

 The Holder or Holders of Registrable Securities included in any registration shall furnish to the Company such information regarding such Holder or Holders, the Registrable Securities held by them and the
distribution proposed by such Holder or Holders as the Company may request in writing and as shall be required in connection with any registration, qualification or compliance referred to in this Section 1. 

 

	 	1.13.	Rule 144 Reporting  

  

	 	1.13.1.	With a view to making available the benefits of certain rules and regulations of the Securities Exchange Commission (“SEC”) that may at any time permit
the sale of the Registrable Securities to the public without registration, after such time as a public market exists for the Company’s ordinary shares, the Company agrees to use its best efforts to: 

 

	 	1.13.1.1.	Make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act, at all times after the effective date that
the Company becomes subject to the reporting requirements of the Securities Act or the Securities Exchange Act of 1934, as amended; 

  

	 	1.13.1.2.	File with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Securities Exchange Act of 1934, as
amended (at any time after it has become subject to such reporting requirements). 

  

	 	1.14.	Transfer of Registration Rights and other Rights. The rights to cause the Company to register Registrable Securities and any other rights afforded to the
Holders pursuant to this Agreement may be assigned, in whole or in part, to any transferee or assignee of a Holder solely in connection with any transfer or assignment of Registrable Securities or Securities exchangeable or convertible into
Registrable Securities held by such Holder effected in accordance with the Company’s Articles of Association, and provided that such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this
Agreement. 

  

	 	1.15.	Market Stand Off. In any registration of Registrable Securities or in the Company’s IPO, the Holders agree to abide by a customary “lock
up” period of up to one hundred and eighty (180) days if so required by the underwriter in such registration, provided that such obligation shall also apply to the officers, directors, and significant shareholders of the Company. For the
purpose of this Section 1.15, the term “significant shareholders” shall mean a holder of at least 10% of the Company’s issued and outstanding share capital on a fully diluted basis immediately prior to such registration.

  
 - 8 -

	 	1.16.	Termination of Registration Rights. Any rights to registration under this Section 1 shall terminate upon the fifth anniversary of the closing of the
Company’s IPO. 

  

	2.	INFORMATION RIGHTS 

Without derogating from any of the rights the Holders might have under the Israeli Companies Law, 1999, until the closing of an IPO, the
Company shall prepare and provide to the Holders the following documents: 
  

	 	2.1.	Within seventy five (75) days after the end of each fiscal year of the Company, annual financial statements (including an audited balance sheet of the Company as
of the end of such year, and audited statements of income and statements of cash flow of the Company for such year), audited by a firm of Independent Certified Public Accountants in the State of Israel who are members of the Israeli Institute of
Certified Public Accountants, and accompanied by an opinion of such firm, which opinion shall state that such financial statements (including the balance sheet and statements of income and cash flow have been prepared in accordance with Israeli GAAP
applied on a basis consistent with that of the preceding fiscal year, and present fairly and accurately the financial position of the Company as of their date, and that the audit by such accountants in connection with such financial statements has
been made in accordance with generally accepted auditing standards; and 

  

	 	2.2.	Within forty five (45) days after the end of each quarter of each fiscal year of the Company, unaudited but reviewed financial statements (including a balance
sheet of the Company as at the end of each such period and unaudited statements of income and cash flow of the Company for such period), accompanied by a brief confidential overview of the operations of the Company for the ended quarter as
shall be prepared by the management of the Company. 

 The information provided by the Company under this
Section 2 shall be held by all recipients in strictest confidence. 
  

	 	2.3.	Accounting. The Company will maintain a system of accounting established and administered in accordance with GAAP consistently applied, and will set aside on its
books all such proper reserves as shall be required by GAAP. 

  

	3.	CANCELLATION OF PREVIOUS AGREEMENTS 

  

	 	3.1.	Cancellation of Voting Agreement. The Company and those of the undersigned which are also parties to that certain Amended & Restated Voting
Agreement dated January 11, 2004 (the “Voting Agreement”), do hereby cancel the Voting Agreement, pursuant to section 5 of the Voting Agreement, and declare that upon their signature hereunder, the Voting Agreement shall have
no force and effect. 

  

	 	3.2.	Cancellation of Certain Sections of Loan Agreements. 

  

	 	3.2.1.	 The Company and those of the undersigned which are also parties to that certain AMENDED AND RESTATED CONVERTIBLE LOAN AGREEMENT dated
July 20, 2003 (the “First Loan Agreement”) and/or that certain Amendment to the amended and restated Convertible Loan Agreement dated December 12, 2003 (the “Second Amendment of the First Loan
Agreement”), do hereby agree to the cancellation of Sections 4 (Loan Repayment), 6 (Business Plan), 7 (Conversion), 

  
 - 9 -

	 	
8 (Protection of Lenders’ Interests), 9 (Board of Directors) and 12 (Information Rights) of the First Loan Agreement and to the cancellation of Section 5 (the
Loan Repayment) of the Second Amendment of the First Loan Agreement, and declare that upon their signature hereunder, such provisions shall have no force and effect. 

 

	 	3.2.2.	 The Company and those of the undersigned which are also parties to that certain Convertible Bridge Loan agreement with Options dated January 18,
2005 (the “2005 Convertible Bridge Loan”), as amended, do hereby agree to the cancellation of Sections 4.2 (Automatic Conversion of Loan in the event of no Next Equity Financing (at the Final Date)), 5 (Repayment), 6
(Exit Events), and 7 (Adjustments) of the 2005 Convertible Bridge Loan and Section 5.2 (Additional Conversion Alternative in the event of an Automatic Conversion of the Loan upon a “Next Equity Financing”) of the
1st Amendment to the Convertible Bridge Loan Agreement
dated January 27, 2005, and declare that upon their signature hereunder, such provision shall have no force and effect. 

  

	4.	BRING ALONG 

 The
Shareholders hereby give their consent to the Bring Along provision set forth in Article 70 of the Company’s Amended Articles attached as Exhibit 6.1.1(a) of the Series B Share Purchase Agreement. 

 

	5.	GENERAL PROVISIONS 

  

	 	5.1.	Entire Agreement. This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the subject matters hereof
and thereof and supersedes any prior understanding or agreement between the parties with regard to the subject matters hereof, including the Former Amended RRA. 

 

	 	5.2.	Validity. This Agreement shall enter into effect subject to and upon fulfillment of each of the following cumulative conditions: (i) receipt of the
signatures of the Required Majority that is required in order to amend the Former RRA and replace it in its entirety with this Agreement; (ii) receipt of the signatures of the majority that is required in order to cancel the Voting Agreement as
set forth in Section 3.1 above; (iii) receipt of the signatures of the majority that is required in order to cancel certain provisions of the First Loan Agreement and of the Second Amendment of the First Loan Agreement as set forth in Section
3.2.1 above; (iv) receipt of the signatures of the majority that is required in order to cancel a certain provision of the 2005 Convertible Bridge Loan as set forth in Section 3.2.2 above; and (v) consummation of the First Closing of the
Series B Share Purchase Agreement (as such term is defined therein). 

  

	 	5.3.	Amendment of Rights. Any provision of this Agreement may be amended and the observance thereof may be waived (either generally or in
a particular instance and either retroactively or prospectively), only with the written consent of the Company and holders of at least 60% (sixty percent) of Registrable Securities then outstanding or issuable upon conversion of Series B-1 Preferred
Shares, Series B Preferred Shares, Series A Preferred Shares, and/or Ordinary-1 Shares then outstanding. Any amendment or waiver affected in accordance with this Section 5.3 shall be binding upon each Holder, each permitted successor or
assignee of the Holder and the Company. 

  
 - 10 -

	 	5.4.	Joining Parties. It is hereby agreed that any New Investor (as defined in the Series B Share Purchase Agreement) participating in the Second Closing of the
Series B Share Purchase Agreement shall become a party to this Agreement, and a “Shareholder” for all intents and purposes hereunder, by singing the Joinder Agreement attached as Exhibit 3.4 of the Series B Share Purchase Agreement.

  

	 	5.5.	Notices. All notices and other communications required or permitted hereunder to be given to a party to this Agreement shall be in writing and shall be
telecopied or mailed by registered or certified mail, postage prepaid, or otherwise delivered by hand or by messenger, addressed to such party’s address as set forth below or at such other address as the party shall have furnished to each other
party in writing in accordance with this provision: 

 if to the Company: as set forth in the Preamble hereto;

 if to the Shareholders: as set forth in Schedule A hereto. 

or such other address with respect to a party as such party shall notify each other party in writing as above provided. Any notice sent
in accordance with this Section 5.5 shall be considered as having reached its destination, if it was delivered by hand, at the time of its delivery; if it was sent by registered mail, within 96 hours from the time it was so dispatched; and if it was
sent by facsimile, within 24 hours from the receipt of the confirmation of proper transmission of the notice. 
  

	 	5.6.	Governing Law; Jurisdiction. This Agreement shall be governed by and construed according to the laws of the State of Israel. Any dispute arising under or
in relation to this Agreement shall be resolved exclusively by the competent courts of Tel-Aviv Jaffa, Israel, and the parties hereto irrevocably submit to the exclusive jurisdiction of such courts for such purposes. 

 

	 	5.7.	Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, then such provision(s) shall be excluded from
this Agreement and the balance of this Agreement shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance with its terms. 

 

	 	5.8.	Third Parties. Nothing in this Agreement, express or implied, is intended to confer upon any person, other than the parties hereto and their permitted
successors and assigns, any rights or remedies under or by reason of this Agreement. 

  

	 	5.9.	Counterparts. This Agreement may be executed in facsimile counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. 

  
 - 11 -

 IN WITNESS WHEREOF, the parties hereto have executed this Investors Rights Agreement as of
the date and year first above written. 
  

							
	 The Company:
	 		 	EVOGENE LTD., by:
			
		 		 	 /s/ Ofer Haviv /s/ Hagai Karchi

		 		 	Name:	 	 Ofer Haviv

		 		 	Title:	 	 CEO

	 The Shareholders:
	 		 		 	
			
		 		 	KADIMA HIGH-TECH LTD., By:
			
		 		 	 /s/ Illegible

		 		 	Name:	 	 Kadima High-Tech Ltd.

		 		 	Title:	 	 Kadima High-Tech Ltd.

			
		 		 	EPIONE BIOINVESTMENT I L.P., By:
			
		 		 	 /s/ Eric Messika

		 		 	Name:	 	 Eric Messika

		 		 	Title:	 	 General Partner

			
		 		 	EPIONE BIOINVESTMENT II L.P., By:
			
		 		 	 /s/ Eric Messika

		 		 	Name:	 	 Eric Messika

		 		 	Title:	 	 General Partner

			
		 		 	HACKMEY JOSEPH
			
		 		 	 /s/ Hackmey Joseph
            

			
		 		 	PIERRE SCHNEIDER
			
		 		 	 /s/ Pierre Schneider

  
 - 12 -

			
	GRYP INVESTMENTS LTD. by:
	
	 /s/ Illegible

	Name:	 	  

	Title:	 	  

	
	PETER WEINREB
	
	  

	
	HUNZA VENTURES S.A. by:
	
	 /s/ Miemile Vogt

	Name:	 	 Miemile Vogt

	Title:	 	 Director

	
	MARK GELFAND
	
	 /s/ Mark Gelfand

	
	COMPUGEN LTD. by:
	
	 /s/ Amos Reltzer

	Name:	 	 Amos Reltzer

	Title:	 	 General Counsel

	
	DR. HAGAI KARCHI
	
	 /s/ Hagai Karchi

	
	DR. RAFAEL MEISSNER
	
	 /s/ Rafael Meissner

  
 - 13 -

			
	LEON RECANATI
	
	 /s/ Leon Recanti

	
	ROBERT H. ASHER
	
	  

	
	CAREMI PARTNERS LTD., By:
	
	 /s/ Steven Ruchefsky

	Name:	 	 Steven Ruchefsky

	Title:	 	 President

	
	MARTIN GERSTEL
	
	 /s/ Martin Gerstel

	
	SHOMAR CORPORATION, By:
	
	 /s/ Marianne Janowsky

	Name:	 	 Marianne Janowsky

	Title:	 	 Chairman

	
	UZI ZUCKER
	
	 /s/ Uzi Zucker

	
	GKW UNIFIED HOLDINGS LLC, By:
	
	 /s/ Kurt Tomitz

	Name:	 	 Kurt Tomitz

	Title:	 	 Chief Financial Officer

	
	SOPHIE DULAC
	
	  

  
 - 14 -

			
	PATRIMOINE INTERNATIONAL HOLDINGS S.A., By:
	
	  

	Name:	 	  

	Title:	 	  

	
	HUGUES D’HAUSSONVILLE
	
	  

	
	PAUL NIZARD
	
	  

	
	YOEL GUILATT
	
	 /s/ Yoel Guilatt

	
	TZINA NIHUL VE YIZUM LTD., By:
	
	 /s/ Illegible

	Name:	 	  

	Title:	 	  

	
	ARISTO VENTURES LTD., By:
	
	 /s/ Meir Leshem

	Name:	 	 Meir Leshem

	Title:	 	 CEO

	
	FRED CRAVES
	
	 /s/ Fred Craves

	
	MORDECHAI SEGAL
	
	  

  
 - 15 -

			
	GOLD POINT INVESTMENT INC.
	
	 /s/ S.N. Ariav

	Name:	 	 S.N. Ariav

	Title:	 	 Attorney-in-Fact

	
	RAMI HAVIV
	
	  

	
	REICH EINAT
	
	 /s/ Einat Reich

	
	GOLDBERG PNINA
	
	 /s/ Pnina Goldberg

	
	BAKER LEONARD
	
	 /s/ G. Leonard Baker

	
	FRIEDKIN MORTON
	
	 /s/ Morton Friedkin

	
	STAFFORD ROBERT
	
	 /s/ Robert Stafford

	
	SHAY FRIEDMAN
	
	 /s/ Shay Friedman

	
	DANNY FLEISHER
	
	 /s/ Danny Fleisher

  
 - 16 -

			
	GAD NOIK
	
	 /s/ Gad Noik

	
	ZERAIM GEDERA LTD., By:
	
	  

	Name:	 	  

	Title:	 	  

  
 - 17 -

 Schedule A – Shareholders’ Addresses 

 

					
	 	  	 Shareholder
	  	 Address

			
	1.	  	Kadima High-Tech Ltd. (as trustee)	  	 c/o Kadima High-Tech Ltd.
 10
Oceanus Building

10th Floor, Suit 1005
 Herzelia Pituach 46555
 Attn: Yossi Ben-Yoseph
 E-mail: yossi@kadimainv.com

 
 With a copy to:

 
 Gornitzky & Co.
 45 Rothschild Blvd. Tel Aviv, 65784
 Fax: +972-3-560-6555

E-mail: gross@Gornitzky.co.il
 Attn: Dubi
Gross, Adv.

			
	2.	  	Epione BioInvestment I L.P.	  	 c/o Epione BioInvestment I L.P.

7 Rival St.
 Beit Amgar, 2nd Floor
 Tel-Aviv 67778
 Attn: Dr. Eric Messika
 E-mail: eric@coronis-partners.com
  
 With a copy to:
  
 Baratz, Horn
& Co. 1 Azrieli Center, Round Tower, 18th Floor Tel Aviv 67021, Israel Tel: 972-3-6073766 Fax: 972-3-6073778 E-mail: y.horn@bar-law.com
 Attn: Yuval Horn, Adv.

			
	3.	  	Epione BioInvestment II L.P.	  	 c/o Epione BioInvestment II L.P.

7 Rival St.
 Beit Amgar, 2nd Floor
 Tel-Aviv 67778
 Attn: Dr. Eric Messika
 E-mail: eric@coronis-partners.com
  
 With a copy to:
  
 Baratz, Horn
& Co. 1 Azrieli Center, Round Tower, 18th Floor Tel Aviv 67021, Israel Tel: 972-3-6073766 Fax: 972-3-6073778 E-mail: y.horn@bar-law.com
 Attn: Yuval Horn, Adv.

  
 - 18 -

					
			
	4.	  	Hackmey Joseph	  	 30 Levantine St.
 Tel-Aviv
65115

			
	5.	  	Pierre Schneider	  	 119 Ave. Gaston Diderich
 B.P.
1163
 L-1011 Luxembourg

			
	6.	  	GRYP Investments Ltd.	  	 8 Hamenofim st. Beit Ofek, 4th floor
 Hertzeliya Pituach
 office: 972-9-9725699
 fax: 972-9-972-5606

			
	7.	  	Peter Weinreb	  	 Rue Ernest Gossart 20
 1180
Brussels
 Belgium

			
	8.	  	Leon Recanati	  	 27 Yoav St. Zahala
 Tel Aviv
69081
 Israel
 Fax:
(972)-3-6472178
 Tel: (972)-3-6075641

			
	9.	  	Robert H. Asher	  	 211 E Chicago Ave 1020
 Chicago
IL 60611
 Fax: (312)-9516171

        (972)-2-6731598
         Tel: (312)-9518957

			
	10.	  	Caremi Partners Ltd.	  	 Two American Lane
 Greenwich CT
06836
 Fax: (203)-8627146
 Tel:
(203)-8614829

			
	11.	  	Martin Gerstel	  	 7 Etiopia St.,
 Jerusalem
95149,
 Israel

			
	12.	  	Shomar Corporation	  	 2 Bradford Road
 Plainview, New
York 11803
 U.S.A.
 Fax:
(516)-9357836
 Tel: (516)-9357848

			
	13.	  	Uzi Zucker	  	 c/o Bear, Stearns & Co. Inc.

383 Madison Ave. –
40th Floor

New York, NY 10179
 Fax: (212)-2729318

Tel: (212)-2723745

  
 - 19 -

					
			
	14.	  	GKW Unified Holdings LLC	  	 360 North Crescent Drive

Beverly Hills, California
 USA
90210-3818
 Fax: (310)-2815831
 Tel:
(310)-4995432

			
	15.	  	Sophie Dulac	  	 86 Avenue Niel
 75017
Paris
 France
 Tel:
0147230025

			
	16.	  	Patrimoine International Holdings S.A.	  	 3 Rue Guillaume Kroll
 L –
1882 Luxembourg
 Fax: (352)-40-45-48

Tel: (352)-40-63-55

			
	17.	  	Hugues d’Haussonville	  	 240 Rue de Rivoli
 75001 Paris,
France
 Fax: (0033)-142961688
 Tel:
(0033)-142961072

			
	18.	  	Paul Nizard	  	 83 Avenue Raymond Poincare

75116 Paris, France
 Fax: 33-147043209

Tel: 33-147044880

  
 - 20 -

					
			
	19.	  	Yoel Guilatt	  	 PO Box 3641
 Kadima
60920
 Fax: 09-8911510
 Tel:
09-8991940

			
	20.	  	Tzina Nihul Ve Yizum Ltd.	  	 9 Hamiktzoa St.
 Tel
Aviv
 Israel
 Fax:
03-6874504
 Tel: 03-5372225
  

			
	21.	  	Aristo Ventures Ltd.	  	 5/39 Fishman Maimon St.
 Tel
Aviv
 Israel
 Fax:
03-5270789
 Tel: 03-5224878

			
	22.	  	Mordechai Segal	  	 33 HaLechi St.
 Herzelia
Pitoach
 Israel
 Tel:
09-9570654
 Fax: 03-6919598 (Kadima Group)
 Tel New York:
 0019178545399

			
	23.	  	Fred Craves	  	 750 Battery St., Suite 400
 San
Francisco, CA 94111
 U.S.A.
 Tel:
415-835-9340
 Fax:415-837-0303

			
	24.	  	Gold Point Investment Inc.	  	 Gold Point Investment Inc.
 c/o
Sucre, Arias, Castro & Reyes
 Edificio Sucre
 Bella Vista, Calle 48
 P.O Box 6277
 PA-Panama 5

  
 - 21 -

					
			
		  		  	 Mailing address:
  

Gold Point Investment Inc.
 c/o Dr. Peter
Kienast
 Bar & Karrer

Seefeldstrasse 19
 CH-8024 Zurich

Switzerland

			
	25.	  	Rami Haviv, Adv. (as trustee for Gabi Gonen Levi)	  	 7 Menachem Begin Road.

Ramat-Gan 52681
 Israel

 
 With a copy to:

 
 holender@netvision.net.il

			
	26.	  	Reich Einat	  	 Harimon st. 7
 Ramat Hashron
47251
 Israel

			
	27.	  	Goldberg Pnina	  	 2 Pamoni St.
 Tel-Aviv
62915
 Israel

			
	28.	  	The Baker Revocable Trust U/A/D 2/3/03	  	 755 Page Mill Road, Suite A-200

Palo Alto, CA 94304
 U.S.A.

Tel: 650-493-5600
 Fax:
650-858-1854

			
	29.	  	Friedkin Morton	  	 44 Montgomery St., 41st Floor
 San
Francisco, CA 94104
 U.S.A.
 Tel:
415-593-3300
 Fax: 415-318-8695

  
 - 22 -

					
			
	30.	  	Stafford Robert	  	 Stafford capital management

222 Kearny Street, Suite 410
 San Francisco, Ca
94108
 U.S.A.
 Fax:
415-362-3048

			
	31.	  	Shay Friedman	  	 40 Edenbridge Drive
 Thornhill,
Ontario L4J 7V1
 Canada

			
	32.	  	Danny Fleisher	  	 17 Hedgewood Road
 Toronto,
Ontario M2L 1L4
 Canada

			
	33.	  	Gad Noik	  	 3410 Shepard Avenue East

Scarborough, Ontario M1T 3K4

Canada

			
	34.	  	Zeraim Gedera Ltd.	  	 P.O. Box 103,
 Gedera
70075,
 Israel

			
	35.	  	Compugen Ltd.	  	 72 Pinchas Rozen St.,
 Tel Aviv
69512
 Israel

  
 - 23 -

					
			
	36.	  	 Rafael Meisner
 (Including in
respect of any shares beneficially owned by Mr. Meisner and held in trust by Debbie Goodman, Adv.)
	  	 10 Mordei Ha’gethaot St.

Rechovat 76464
 Israel

			
	37.	  	 Hagai Karchi
 (Including in
respect of any shares beneficially owned by Mr. Karchi and held in trust by Debbie Goodman, Adv.)
	  	 249 Sapir St.
 Moshav
Sitria
 Israel

			
	38.	  	Hunza Ventures S.A.	  	 Hunza Ventures SA
 Boulevard
Joseph II 40
 1840 Luxembourg
 Tel 352
45 31 31
 Fax 352 45 31 33

			
	39.	  	Mark Gelfand	  	 89 Newton St.
 Apt 2443,
Newton,
 Massachusetts 02461

USA

  
 - 24 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00223-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00223-of-00352.parquet"}]]